Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Broad Institute, Quantum-Si, Element Biosciences, More

Broad Institute: Eric Schmidt

Eric Schmidt has been appointed as chair of the Broad Institute's board of directors. He will begin his term on June 8 and will succeed Louis Gerstner Jr., who has served as chair of the board since 2013. Schmidt joined the board in 2012. He is the former CEO and chair of Google and a cofounder of Schmidt Futures, a philanthropy organization. Prior to Google, he held leadership positions at Novell and Sun Microsystems.

Quantum-Si: Claudia Napal Drayton

Claudia Napal Drayton has been appointed as CFO of proteomics firm Quantum-Si. Previously, she was CFO at CHF Solutions. Before that, she held various positions at Medtronic, including CFO and senior finance director of the firm's Integrated Health Solutions business. Drayton holds an MBA from the Carlson School of Management at the University of Minnesota and a bachelor of business administration in accounting from the University of Mary Hardin-Baylor.

Element Biosciences: Jeff Journey, David Melaugh, Jeff Labbadia

Element Biosciences, a San Diego startup developing next-generation sequencing technologies, has made several appointments to its management team.

Jeff Journey has been named the firm's chief commercial officer. Most recently, he was VP and general manager at Thermo Fisher Scientific, where he oversaw the sample preparation business unit. Prior to that, he held various marketing, sales, service and support, and strategy roles at Thermo Fisher, Johnson & Johnson, and General Electric. He is also a veteran of the US Air Force.

David Melaugh has been appointed as general counsel. He joins Element from Apple, where he was senior director of the worldwide intellectual property litigation team. Prior to that, he was a partner at Morrison & Foerster.

Jeff Labbadia has joined Element as VP of operations. Previously, he spent 22 years at Becton Dickinson, where he held various global operations leadership roles.

For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.